Abstract
Objective-To assess current clinical practice in coronary artery bypass surgery and compare it with a previous survey conducted five years ago. Setting-United Kingdom. Design-Postal questionnaires were sent in March 1993 to 120 consultant cardiac surgeons currently performing coronary artery bypass surgery. 104 (87%) were returned by May 1993. Results-The 104 surgeons who returned the questionnaire performed an estimated total of 25 234 coronary artery bypass operations in 1992 with an average case load per surgeon similar to that in 1987 (243 v 214, NS). The internal mammary artery was regarded as the conduit of choice by 101 surgeons (97%) and was used in 93% of bypass grafts to the left arterior descending coronary artery compared with 73% in 1987 (p < 0.001) but only in 7% of grafts to the circumflex and right coronary systems. There was also a significant increase in the number of surgeons using both internal mammary arteries (88% v 59/o, p < 0.01) but only a small increase in those using the internal mammary artery as a sequential graft (55% v 44%, NS). The age of the patient remains one of the main contraindications to the use of the internal mammary artery (40%), together with insufficient mammary flow (42%), endarterectomy (22%), and unstable angina (17%). The Operations/yr Most surgeons regard the internal mammary artery as the conduit of choice for coronary artery bypass grafting. Compared with the previous survey there has been a significant increase in the percentage of grafts to the left anterior descending artery constructed with the internal mammary artery, and also an increase in the use of both mammary arteries in the same patient. The percentage of grafts to the circumflex and right coronary systems performed with the internal mammary artery remains small.
Among perceived contraindications to the use of the internal mammary artery, advanced age of the patient, insufficient mammary flow, endarterectomy, combined procedure, and unstable angina were cited most commonly. There is a significant reduction in the number of surgeons who regard these as contraindications compared with five years earlier, suggesting that the use of the mammary artery has been extended to these groups of patients.
The data clearly show a significant overall increase in the use of the internal mammary artery compared with five years earlier. The right gastroepiploic and inferior epigastric arteries were used occasionally and only when the internal mammary artery or the saphenous vein were not available. This reservation about a more liberal use of these arterial grafts is perhaps a reflection of the lack of information about the long-term performance of these conduits in large groups of patients.
Similar to the previous survey, antiplatelet treatment remains widely used due to its proved efficacy in decreasing early graft failure.13 14 Although more surgeons prescribe aspirin for longer periods, dipyridamole has largely disappeared from routine use, both on a temporary and permanent basis. Warfarin is currently restricted almost exclusively to patients who have undergone endarterectomy.
Unlike the previous study, in this survey we also investigated the current practice of myocardial protection. Cardioplegic arrest was the favoured technique, although 19% of surgeons used intermittent aortic crossclamping and fibrillation. There seems to be an equal split between surgeons who preferred blood cardioplegia or crystalloid cardioplegia. The recently advocated techniques of retrograde cardioplegia and continuous warm cardioplegia do not seem to have gained much popularity.
The results of this survey indicate a general consensus of opinion among British cardiac surgeons that the internal mammary artery is the graft conduit of choice. A more extensive use of this conduit has been made compared with five years earlier. As many patients require more than one or two grafts, the saphenous vein remains widely used despite its poor long-term graft patency. There seems to be a cautious approach to the use of alternative arterial grafts, reflecting a lack of follow up information on patients with these conduits.
We thank the cardiac surgeons in the United Kingdom for responding to the survey and providing our data. Breckenridge IM. Coronary artery bypass surgery: current practice in the United Kingdom. Patients with the so-called "malignant vasovagal syndrome" who have a predominantly cardioinhibitory response to head-up tilting may reasonably be expected to be cured or substantially improved by pacing to abolish bradycardia during attacks. Indeed there is evidence to suggest that a substantial proportion of such patients do well with dual chamber (DDI) pacing.' Sra et al from Milwaukee cast doubt on the effectiveness of such therapy (see abstract below). In their study of 70 patients with hypotension and syncope during tilt table testing six patients had asystole and 16 had significant bradycardia, defined as a heart rate less than 60 beats/min with a fall of more than 20 beats/min. These patients were restudied during temporary dual chamber pacing or, in the presence of atrial fibrillation, ventricular pacing.
Despite pacing, 20 of these 22 patients experienced syncope or presyncope during repeat tilt table testing, which was associated with a fall in blood pressure. One patient became dizzy with a fall in blood pressure of only 20 mm Hg. One patient had a negative test with pacing and was therefore treated by permanent dual chamber pacing. Subsequently symptoms recurred in this patient.
By contrast, 18 of 19 patients who were treated with metoprolol, theophylline, or disopyramide and tested again had negative tilt table tests and were symptom free at long term follow up, as were three patients treated with both pacing and medical therapy. It is not clear why pacing failed to prevent syncope and presyncope in this group of patients. Certainly the onset of hypotension often preceded the onset of bradycardia by up to 2 minutes (mean 45 seconds), suggesting that bradycardia may be a secondary phenomenon in many patients. However, pacing did result in a lower fall in mean arterial blood pressure (from 98 to 37 mm Hg before and from 97 to 57 mm Hg after pacing) and may therefore lessen symptoms. Moreover, pacing may also reduce the rate of decline in blood pressure thereby preventing a "drop attack" and giving the patient time to react to presyncopal symptoms and reducing the risk of serious injury.
Despite these qualifications the clear message from Sra et al is that medical therapy should be regarded as the first-line treatment for vasovagal syncope even in the face of important bradycardia and that pacing has a low chance of success.
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